152 related articles for article (PubMed ID: 8772547)
1. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
Anderson RA; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
[TBL] [Abstract][Full Text] [Related]
2. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
3. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
4. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
6. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
[TBL] [Abstract][Full Text] [Related]
8. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
[TBL] [Abstract][Full Text] [Related]
9. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone.
Matsumoto AM; Karpas AE; Paulsen CA; Bremner WJ
J Clin Invest; 1983 Sep; 72(3):1005-15. PubMed ID: 6411766
[TBL] [Abstract][Full Text] [Related]
10. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
Matsumoto AM; Karpas AE; Bremner WJ
J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility.
Lancet; 1990 Oct; 336(8721):955-9. PubMed ID: 1977002
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone.
Pavlou SN; Interlandi JW; Wakefield G; Rivier J; Vale W; Rabin D
J Androl; 1986; 7(4):228-33. PubMed ID: 3528106
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
[TBL] [Abstract][Full Text] [Related]
14. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
Pangkahila W
Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
[TBL] [Abstract][Full Text] [Related]
15. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
[TBL] [Abstract][Full Text] [Related]
16. The potential for an androgen male contraceptive.
Cunningham GR; Silverman VE; Thornby J; Kohler PO
J Clin Endocrinol Metab; 1979 Oct; 49(4):520-6. PubMed ID: 479345
[TBL] [Abstract][Full Text] [Related]
17. Is high dosage testosterone an effective male contraceptive agent?
Matsumoto AM
Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
[TBL] [Abstract][Full Text] [Related]
18. Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception.
Wu FC; Aitken RJ
Fertil Steril; 1989 Apr; 51(4):691-8. PubMed ID: 2522398
[TBL] [Abstract][Full Text] [Related]
19. The effects of exogenous testosterone on sexuality and mood of normal men.
Anderson RA; Bancroft J; Wu FC
J Clin Endocrinol Metab; 1992 Dec; 75(6):1503-7. PubMed ID: 1464655
[TBL] [Abstract][Full Text] [Related]
20. Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. World Health Organization Task force on Methods for The Regulations of Male Fertility.
Int J Androl; 1995 Jun; 18(3):157-65. PubMed ID: 7558380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
